Islets is a vital academic journal dedicated to advancing our understanding of the complex mechanisms underlying islet biology and its implications in health and disease. Published by Taylor & Francis Inc, this journal aims to serve as a premier platform for researchers, clinicians, and students engaged in the fields of Endocrinology, Diabetes, and Metabolism. With a focus on publishing high-quality research articles, reviews, and clinical studies, Islets seeks to contribute significantly to the ongoing dialogue in these critical areas of biomedical research. Boasting a Category Quartile of Q3 in both Endocrinology and Endocrinology, Diabetes and Metabolism, as well as relevant Scopus rankings that underscore its role in the research community, Islets provides an essential resource for those looking to stay informed and make impactful contributions to the field. While offering exclusive insights from 2009 to 2024, the journal encourages an open exchange of ideas that paves the way for future discoveries and advancements in islet research.

The United European Gastroenterology Journal, published by John Wiley & Sons Ltd, is a leading publication in the fields of gastroenterology and oncology, boasting a distinguished Q1 ranking in both categories for 2023. With an ISSN of 2050-6406 and an E-ISSN of 2050-6414, this journal serves as a vital platform for disseminating cutting-edge research and innovative practices from 2013 to 2024, supporting the advancement of knowledge in gastrointestinal health and cancer treatment. With a commendable Scopus Rank of 14th out of 167 in gastroenterology and 54th out of 404 in oncology, it emphasizes the significance of impactful research in these critical areas. While currently not an open-access journal, it remains a vital resource for researchers, professionals, and students seeking comprehensive insights and evidence-based approaches to improve patient care and clinical outcomes. The United European Gastroenterology Journal is committed to bridging the gap between research and practice, making it an essential reference for those dedicated to the fields of gastroenterology and oncology.

The European Thyroid Journal, published by BIOSCIENTIFICA LTD, is a premier open-access journal that has been delivering high-quality research in the field of endocrinology since its inception. With an ISSN of 2235-0640 and an E-ISSN of 2235-0802, this journal serves as a vital resource for researchers, clinicians, and students focused on the latest developments in thyroid disease, diagnosis, and treatment. Located in Switzerland and currently enjoying a Q2 ranking in the Endocrinology, Diabetes, and Metabolism category for 2023, it ranks an impressive 71st out of 244 journals in its field, underscoring its significant impact, as evidenced by its substantial impact factor. The journal’s commitment to open access since 2022 enhances its accessibility and reach, ensuring that groundbreaking findings are disseminated swiftly and widely. By bridging knowledge across the endocrine research community, the European Thyroid Journal plays an instrumental role in advancing the understanding and management of thyroid-related disorders, making it an invaluable asset for anyone involved in this critical area of health.

Pancreatology is a prestigious journal published by ELSEVIER, focusing on the multifaceted disciplines of endocrinology, diabetes, gastroenterology, and hepatology since its inception in 2001. With an impressive Q1 ranking in multiple categories, including Endocrinology and Gastroenterology, Pancreatology stands out as a critical platform for disseminating peer-reviewed research that contributes to the evolving understanding of pancreatic diseases and associated metabolic disorders. This journal has gained significant recognition in the academic community, underscored by its robust Scopus rankings, positioning it favorably among its peers. While it currently does not offer open access, Pancreatology remains committed to advancing knowledge through high-quality publications and fostering innovation in clinical practice and research. Researchers, professionals, and students are invited to engage with the cutting-edge findings within its pages, which are essential for driving progress in this essential area of medicine.

PANCREAS, published by Lippincott Williams & Wilkins, is a preeminent journal dedicated to advancing the field of endocrinology, diabetes, hepatology, and internal medicine. With an ISSN of 0885-3177 and E-ISSN of 1536-4828, this journal aims to disseminate high-quality research findings and clinical insights that are pivotal for professionals in these areas. The journal has established itself with an impressive Q2 ranking across multiple categories in the 2023 rankings, including endocrinology, diabetes and metabolism, hepatology, and internal medicine. Although it offers no open access options, the content is meticulously curated to enrich the knowledge base of researchers and practitioners. The Scopus rankings further underscore its influence, ranking #64 in Internal Medicine and #36 in Hepatology, reflecting its commitment to scholarly excellence. Based in the United States at Two Commerce Square, 2001 Market St, Philadelphia, PA 19103, PANCREAS serves as a central hub for innovative research from 1986 to 2024, making it an essential resource for those engaged in these rapidly evolving fields.

HPB is a premier journal dedicated to advancing the fields of Gastroenterology and Hepatology, published by Elsevier Science Ltd. With an impressive impact factor reflective of its high-quality research output, HPB has earned its place as a Q1 journal in Gastroenterology and Q2 in Hepatology as of 2023. The journal, available in both print and electronic formats (ISSN: 1365-182X; E-ISSN: 1477-2574), serves as a vital platform for multidisciplinary research, encompassing clinical and experimental studies, aimed at improving patient care and outcomes related to liver and biliary diseases. Since its inception in 2000, HPB has published influential articles that have shaped practice and policy in the field. Located in the United Kingdom, at 125 London Wall, London EC2Y 5AS, the journal is poised to continue its mission of fostering innovation and collaboration among researchers, healthcare professionals, and academicians worldwide.

International Journal of Hepatobiliary and Pancreatic Diseases (ISSN: 2230-9012) is a pivotal publication dedicated to advancing knowledge in the fields of hepatology, biliary tract, and pancreatic diseases. Published by EDORIUM JOURNALS, this esteemed journal aims to provide a platform for cutting-edge research, critical reviews, and clinical studies that address complex issues affecting the liver, biliary system, and pancreas. With a strong commitment to open access, the journal facilitates the dissemination of vital findings to researchers, clinicians, and healthcare professionals worldwide. Recognizing the importance of these disciplines in combating global health challenges, the International Journal of Hepatobiliary and Pancreatic Diseases welcomes submissions that contribute to the understanding of pathophysiology, treatment advancements, and innovative surgical techniques. For researchers eager to impact patient care and medical knowledge, this journal serves as an essential resource in the ongoing dialogue on liver and pancreatic health.

Clinical and Experimental Gastroenterology is a prestigious Open Access journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing the field of gastroenterology through rigorous research and innovative insights. With its ISSN 1178-7023, the journal has established a significant presence since its inception in 2008 and has been actively contributing to the academic landscape from New Zealand. The journal has attained a commendable Q2 rank in the Gastroenterology category as of 2023, placing it in the upper-tier percentile of similar journals. It currently ranks #57 out of 167 in the Scopus database, highlighting its relevance and impact in the field at the 66th percentile. Encompassing a wide range of topics within gastroenterology, the journal aims to foster discussion and disseminate findings that enhance clinical practices and patient care. Researchers, healthcare professionals, and students alike will find this journal an invaluable resource for cutting-edge research and developments in gastrointestinal health.

Korean Journal of Internal Medicine, ISSN 1226-3303, E-ISSN 2005-6648, published by the Korean Association of Internal Medicine, stands as a vital resource in the field of internal medicine. Since its inception in 1961 and the shift to open access in 1986, this journal has consistently provided a platform for innovative research and clinical practices, contributing significantly to the advancement of medical knowledge in South Korea and beyond. With an impressive 2023 impact factor and a Q2 quartile ranking among internal medicine journals, it occupies a commendable position in Scopus rankings, holding the #54 slot out of 167 in the category. The journal emphasizes the dissemination of high-quality research findings, clinical reviews, and case reports, making it indispensable for researchers, professionals, and students eager to stay at the forefront of internal medicine. For authors and readers alike, the journal fosters an engaged and informed community, supporting the continuing education and professional development necessary in today's rapidly evolving medical landscape.

Welcome to the Journal of Central Nervous System Disease, a premier Open Access publication dedicated to advancing the understanding of neurological disorders and their underlying mechanisms. Published by SAGE Publications Ltd, this esteemed journal has been serving the scientific community since 2009 and is committed to disseminating high-quality research that spans from clinical neurology to cellular and molecular neuroscience. With an impressive impact factor, the journal ranks within the top quartiles—Q2 in both Neurology and Clinical Neurology, and Q3 in Cellular and Molecular Neuroscience as of 2023. The journal's indexing in Scopus reflects its significant contribution to the field, being ranked #83 out of 400 in clinical neurology and #38 out of 97 in cellular and molecular neuroscience. This essential resource, based in the United States, is crucial for researchers, clinicians, and students looking to stay at the forefront of neurological science. By providing Open Access options, we ensure that groundbreaking research is readily available to a global audience, fostering collaboration and innovation in the study of central nervous system diseases.